Skip to content

Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00971477
Enrollment
64
Registered
2009-09-03
Start date
2009-08-31
Completion date
2010-06-30
Last updated
2010-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Keywords

Teledermatology, Telemedicine, Psoriasis

Brief summary

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of psoriasis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction. The investigators' hypotheses include the following: 1. Compared to in-person visits, the online care model will result in similar clinical improvement in psoriasis disease severity. 2. Compared to in-person visits, the online care model will result in similar improvements in quality of life. 3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Interventions

Patients randomized to the intervention group will have their scheduled follow-up visits online via a store and forward teledermatology modality.

Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older at time of consent, may be men or women. * Requiring treatment of psoriasis for medically-indicated reasons. * Capable of giving informed consent. * Able to have their skin imaged by themselves or by family members.

Exclusion criteria

* Non-English speaking individuals. * Individuals lacking access to a digital camera and computer with internet connection.

Design outcomes

Primary

MeasureTime frame
Psoriasis Area Severity Index (PASI)Every 6-8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026